Xingwen Su

1.5k total citations
30 papers, 753 citations indexed

About

Xingwen Su is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xingwen Su has authored 30 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xingwen Su's work include Virus-based gene therapy research (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Venomous Animal Envenomation and Studies (5 papers). Xingwen Su is often cited by papers focused on Virus-based gene therapy research (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Venomous Animal Envenomation and Studies (5 papers). Xingwen Su collaborates with scholars based in China, United States and Malaysia. Xingwen Su's co-authors include Pengxin Qiu, Guangmei Yan, Yan Guang-mei, Wei Yin, Yijun Huang, Wenbo Zhu, Mingtao Li, Songnian Hu, Qinghua Liu and Wenya Wang and has published in prestigious journals such as Nature Communications, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Xingwen Su

30 papers receiving 740 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xingwen Su 392 289 121 76 73 30 753
Stefano Gastaldello 792 2.0× 171 0.6× 311 2.6× 24 0.3× 46 0.6× 37 1.3k
Yan Guang-mei 330 0.8× 277 1.0× 17 0.1× 11 0.1× 89 1.2× 29 615
Christopher Ford 411 1.0× 65 0.2× 111 0.9× 16 0.2× 25 0.3× 21 952
M Nishizawa 1.2k 3.0× 392 1.4× 226 1.9× 13 0.2× 43 0.6× 28 2.0k
Mizuki Ohno 1.1k 2.8× 338 1.2× 98 0.8× 4 0.1× 12 0.2× 32 1.6k
Cornelia H. de Moor 1.9k 4.9× 209 0.7× 98 0.8× 49 0.6× 5 0.1× 37 2.4k
H. Desmond 766 2.0× 476 1.6× 95 0.8× 3 0.0× 194 2.7× 23 1.4k
Ralph SCHALOSKE 592 1.5× 228 0.8× 25 0.2× 3 0.0× 36 0.5× 14 967
Iván Conte 1.1k 2.7× 240 0.8× 34 0.3× 27 0.4× 4 0.1× 50 1.5k
Marco Piccinini 564 1.4× 81 0.3× 107 0.9× 4 0.1× 64 0.9× 50 1.0k

Countries citing papers authored by Xingwen Su

Since Specialization
Citations

This map shows the geographic impact of Xingwen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwen Su more than expected).

Fields of papers citing papers by Xingwen Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwen Su. The network helps show where Xingwen Su may publish in the future.

Co-authorship network of co-authors of Xingwen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwen Su. A scholar is included among the top collaborators of Xingwen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwen Su. Xingwen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Wenbo, Jiankai Liang, Jingyi Tan, et al.. (2021). Real-Time Visualization and Quantification of Oncolytic M1 Virus In Vitro and In Vivo. Human Gene Therapy. 32(3-4). 158–165. 12 indexed citations
2.
Liu, Yang, Jing Cai, Wenfeng Liu, et al.. (2020). Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade. Cell Death and Disease. 11(12). 1062–1062. 45 indexed citations
3.
Liang, Jiankai, Li Guo, Kai Li, et al.. (2018). Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus. Nature Communications. 9(1). 1524–1524. 24 indexed citations
4.
Zhang, Haipeng, Kai Li, Yuan Lin, et al.. (2017). Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. Science Translational Medicine. 9(404). 53 indexed citations
5.
Yin, Wei, Zongji Wang, Qiye Li, et al.. (2016). Evolutionary trajectories of snake genes and genomes revealed by comparative analyses of five-pacer viper. Nature Communications. 7(1). 13107–13107. 74 indexed citations
6.
Yan, Min, Ailing Liu, Lipeng Tang, et al.. (2015). Characterization of a Synthetic Steroid 24‐keto‐cholest‐5‐en‐3β, 19‐diol as a Neuroprotectant. CNS Neuroscience & Therapeutics. 21(6). 486–495. 6 indexed citations
7.
Leng, Tiandong, Ailing Liu, Xinying Chen, et al.. (2015). Naturally occurring marine steroid 24-methylenecholestane-3β,5α,6β,19-tetraol functions as a novel neuroprotectant. Steroids. 105. 96–105. 13 indexed citations
8.
Zheng, Xiaoke, Yanqiu Ou, Minfeng Shu, et al.. (2014). Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathway. Molecular Medicine Reports. 9(5). 1773–1779. 11 indexed citations
9.
Li, Jingjie, Sihan Wu, Shifeng Li, et al.. (2012). Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer. Pancreas. 41(7). 1029–1038. 40 indexed citations
10.
Li, Shifeng, Xiaoxiao Yang, Wande Li, et al.. (2012). N-Acetylcysteine Downregulation of Lysyl Oxidase Activity Alleviating Bleomycin-Induced Pulmonary Fibrosis in Rats. Respiration. 84(6). 509–517. 31 indexed citations
11.
Chen, Lijun, Wande Li, Shifeng Li, et al.. (2010). Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts. Acta Pharmacologica Sinica. 31(5). 554–559. 9 indexed citations
12.
Zhu, Wenbo, Yan Li, Pengxin Qiu, et al.. (2009). Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells. Vascular Pharmacology. 52(1-2). 46–54. 33 indexed citations
13.
Su, Xingwen. (2008). Recent status and future of converter slag utilization technology in Anshan Iron & Steel Groups Corporation. Mining Engineering. 1 indexed citations
14.
Liu, Ailing, Xin Wei Wang, Aihua Liu, et al.. (2008). JNK and p38 were involved in hypoxia and reoxygenation-induced apoptosis of cultured rat cerebellar granule neurons. Experimental and Toxicologic Pathology. 61(2). 137–143. 17 indexed citations
15.
Wang, Rongrong, Pengxin Qiu, Xiaofeng Cai, et al.. (2008). Recombinant fibrinogenase from Agkistrodon acutus venom protects against sepsis via direct degradation of fibrin and TNF-α. Biochemical Pharmacology. 76(5). 620–630. 10 indexed citations
16.
Qiu, Pengxin, et al.. (2006). Recombinant production of fibrinogenase IV from Agkistrodon acutus venom and its preliminary evaluation. Applied Microbiology and Biotechnology. 72(1). 72–76. 2 indexed citations
17.
Liu, Qinghua, Xiaowei Zhang, Wei Yin, et al.. (2006). A catalog for transcripts in the venom gland of the Agkistrodon acutus: Identification of the toxins potentially involved in coagulopathy. Biochemical and Biophysical Research Communications. 341(2). 522–531. 60 indexed citations
18.
Su, Xingwen. (2003). Zuogui Pill Protects Rat Cerebellar Granule Neurons From Apoptosis Induced by Glutamate. Zhongguo shiyan fangjixue zazhi. 1 indexed citations
19.
Wang, Wenya, Leyu Shi, Yuanbin Xie, et al.. (2003). SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson’s disease. Neuroscience Research. 48(2). 195–202. 134 indexed citations
20.
Qiu, Pengxin, Mingtao Li, Xiaoli Tang, et al.. (2000). Protective Effects of Polysaccharide from Holothuria atra on Apoptosis of Cortical Neurons Induced by Amyloid beta-Protein. Zhongcaoyao. 31(4). 271–274. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026